Description
In this issue of Clinics in Liver Disease, guest editor Dr. Vinod K. Rustgi brings his considerable expertise to the topic of Current and Next Generation Therapeutics in Hepatology. Top experts in hepatology provide updates on the latest pharmaceuticals available as well as those in the pipeline for a wide range of liver diseases.- Contains 11 relevant, practice-oriented topics including primer of CRISPR: gene therapy and molecular therapies; evolving treatments of cirrhosis; what is coming in the world of liver transplantation; weight loss drugs: current and future implications for liver disease; sensors and wearables in hepatology; and more- Provides in-depth clinical reviews on current and next generation therapeutics in hepatology, offering actionable insights for clinical practice- Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews
Table of Contents
Liver-Directed Molecular Therapies: Current and Upcoming StrategiesNew Approaches to Alcohol-Associated HepatitisTherapies and Pipeline for Hepatitis B and Hepatitis DRecent Advances in Primary Biliary Cholangitis TreatmentCurrent Status and Future Directions in the Pharmacologic Management of CirrhosisNovel Therapeutics for Hepatocellular CarcinomaCurrent Focus and Innovation in Liver TransplantationRadiomics in Hepatology: Therapeutic Applications in Hepatocellular CarcinomaCurrent and Future Implications of Weight Loss Drugs on Liver DiseaseArtificial Intelligence and Machine Learning Applications in Liver DiseasePediatric Liver Diseases: Next-Generation TherapiesFuture Treatment Options for Managing Primary Sclerosing Cholangitis and Cholestatic Pruritus
